Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
Wave Life Sciences (WVE) has announced it will host a live webcast and conference call on Thursday, May 8, 2025, at 8:30 a.m. ET to discuss its first quarter 2025 financial results and provide business updates. The clinical-stage biotechnology company, which focuses on RNA medicines development, will make the webcast accessible through their investor relations website. Analysts can participate in the Q&A session by dialing (833) 630-1956 for domestic calls or (412) 317-1837 for international calls. An archived version of the webcast will be available on the company's website after the live event.
Wave Life Sciences (WVE) ha annunciato che terrà una diretta web e una conference call giovedì 8 maggio 2025, alle 8:30 ET per discutere i risultati finanziari del primo trimestre 2025 e fornire aggiornamenti aziendali. La società biotecnologica in fase clinica, specializzata nello sviluppo di farmaci a base di RNA, renderà la diretta disponibile tramite il sito web delle relazioni con gli investitori. Gli analisti potranno partecipare alla sessione di domande e risposte chiamando il numero (833) 630-1956 per chiamate nazionali o (412) 317-1837 per chiamate internazionali. Una versione registrata della diretta sarà disponibile sul sito aziendale dopo l'evento live.
Wave Life Sciences (WVE) ha anunciado que realizará una transmisión en vivo y una conferencia telefónica el jueves 8 de mayo de 2025 a las 8:30 a.m. ET para discutir los resultados financieros del primer trimestre de 2025 y proporcionar actualizaciones comerciales. La empresa biotecnológica en etapa clínica, que se enfoca en el desarrollo de medicamentos de ARN, hará la transmisión accesible a través de su sitio web de relaciones con inversionistas. Los analistas podrán participar en la sesión de preguntas y respuestas llamando al (833) 630-1956 para llamadas nacionales o al (412) 317-1837 para llamadas internacionales. Una versión archivada de la transmisión estará disponible en el sitio web de la empresa después del evento en vivo.
Wave Life Sciences (WVE)는 2025년 5월 8일 목요일 오전 8시 30분(동부시간)에 2025년 1분기 재무 결과와 사업 업데이트를 논의하기 위한 라이브 웹캐스트 및 컨퍼런스 콜을 개최할 예정이라고 발표했습니다. RNA 의약품 개발에 주력하는 임상 단계 바이오테크 회사인 이 회사는 투자자 관계 웹사이트를 통해 웹캐스트를 제공할 예정입니다. 애널리스트들은 국내 전화는 (833) 630-1956, 국제 전화는 (412) 317-1837로 전화하여 Q&A 세션에 참여할 수 있습니다. 라이브 이벤트 후 회사 웹사이트에서 웹캐스트 녹화본을 시청할 수 있습니다.
Wave Life Sciences (WVE) a annoncé qu'elle tiendra une webdiffusion en direct et une conférence téléphonique le jeudi 8 mai 2025 à 8h30 ET pour discuter des résultats financiers du premier trimestre 2025 et fournir des mises à jour commerciales. Cette société biotechnologique en phase clinique, spécialisée dans le développement de médicaments à base d'ARN, rendra la webdiffusion accessible via son site web pour les relations investisseurs. Les analystes pourront participer à la session de questions-réponses en appelant le (833) 630-1956 pour les appels nationaux ou le (412) 317-1837 pour les appels internationaux. Une version archivée de la webdiffusion sera disponible sur le site de la société après l'événement en direct.
Wave Life Sciences (WVE) hat angekündigt, am Donnerstag, den 8. Mai 2025, um 8:30 Uhr ET eine Live-Webcast und Telefonkonferenz abzuhalten, um die Finanzergebnisse des ersten Quartals 2025 zu besprechen und Geschäftsaktualisierungen zu geben. Das klinisch orientierte Biotechnologieunternehmen, das sich auf die Entwicklung von RNA-Medikamenten spezialisiert hat, wird den Webcast über seine Investor-Relations-Website zugänglich machen. Analysten können an der Fragerunde teilnehmen, indem sie für Inlandsanrufe die Nummer (833) 630-1956 und für internationale Anrufe (412) 317-1837 wählen. Eine archivierte Version des Webcasts wird nach der Live-Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, May 8, 2025, to review the company’s first quarter 2025 financial results and provide business updates.
The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events.
Analysts planning to participate during the Q&A portion of the live call can join the conference call by dialing (833) 630-1956 (domestic) or (412) 317-1837 (international).
Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s diversified pipeline includes clinical programs in Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity, as well as several preclinical programs utilizing the company’s broad RNA therapeutics toolkit. Driven by the calling to “Reimagine Possible”, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X (formerly Twitter) and LinkedIn.
Contact:
Kate Rausch
VP, Corporate Affairs and Investor Relations
+1 617-949-4827
Investors:
InvestorRelations@wavelifesci.com
Media:
MediaRelations@wavelifesci.com
FAQ
When will Wave Life Sciences (WVE) report Q1 2025 earnings?
How can analysts join Wave Life Sciences' Q1 2025 earnings call?
Where can investors access Wave Life Sciences' Q1 2025 earnings webcast?
What is Wave Life Sciences' main business focus?
